Two-Week Wait patients are those with potentially cancerous lesions, due to the potential high risk, the standard is that the patients should be seen within 14 days. There is a huge demand for this service, however many of the lesions referred are benign. In order to differentiate the two, typically patients would previously be seen by a dermatologist in a face-to-face appointment.
The teledermatology pathway instead gives the patients an appointment with a medical photographer, with a high-resolution camera, and the photos are reviewed by the consultant the next day. Patients also fill out a questionnaire on Isla prior to their appointment, and the responses are stored and managed securely via Isla, a digital platform designed specifically for this purpose.
Isla integrates seamlessly with existing clinical systems and has been easy for patients and clinicians to use.
The aim of Two-Week Wait Telederm is to streamline the pathway, allow for shorter appointment times and provide clinicians with the information needed to make a swift diagnosis, reducing waiting lists and meeting the 14-day standard.
See health differently
© 2023 ISLACARE LTD a company registered in England & Wales company registration number 12108076
Find out more